Salona Global terminates CEO Luke Faulstick, appoints Michael Seckler as interim CEO

EVOME MEDICAL TECHNOLOGIES INC.

Luke Faulstick terminated as President and CEO effective June 13, 2023; remains on the board.
Michael Seckler appointed Interim CEO; previously senior executive at Ferring/FerGene.
Joseph Martinez terminated as SVP Legal, General Counsel, Secretary; available as hourly consultant.
Company prioritizing cash flow from operations and debt restructuring per chairman.
Seckler receives $100k salary, up to $200k variable comp, and 250,000 options at CAD$0.25.

item 1.01 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Luke Faulstick

President and Chief Executive Officer

EVOME MEDICAL TECHNOLOGIES INC.

Effective: 2023-06-13
Successor: Michael Seckler
Filed: June 20, 2023, 7:59 PM ET

On June 13, 2023, Salona Global Medical Device Corporation (the "Company") exercised its right to terminate the employment of Luke Faulstick as the Company's President and Chief Executive Officer.

Departed

Joseph Martinez

Senior Vice President, Legal & Compliance, General Counsel and Secretary

EVOME MEDICAL TECHNOLOGIES INC.

Effective: 2023-06-13
Filed: June 20, 2023, 7:59 PM ET

on June 13, 2023 he ceased to hold the titles of Senior Vice President, Legal & Compliance, General Counsel and Secretary of the Company.

Appointed (interim)

Michael Seckler

Interim Chief Executive Officer

EVOME MEDICAL TECHNOLOGIES INC.

Effective: 2023-06-13
Filed: June 20, 2023, 7:59 PM ET

On June 13, 2023, upon terminating Mr. Faulstick, the Company appointed Michael Seckler, 58, to the position of Interim Chief Executive Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Luke Faulstick was terminated as President and Chief Executive Officer at EVOME MEDICAL TECHNOLOGIES INC..

Action: terminated
Role: President and Chief Executive Officer

Exact text from the filing

On June 13, 2023, Salona Global Medical Device Corporation (the "Company") exercised its right to terminate the employment of Luke Faulstick as the Company's President and Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph Martinez was terminated as Senior Vice President, Legal & Compliance, General Counsel and Secretary at EVOME MEDICAL TECHNOLOGIES INC..

Action: terminated
Role: Senior Vice President, Legal & Compliance, General Counsel and Secretary

Exact text from the filing

on June 13, 2023 he ceased to hold the titles of Senior Vice President, Legal & Compliance, General Counsel and Secretary of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Seckler was appointed as Interim Chief Executive Officer at EVOME MEDICAL TECHNOLOGIES INC..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

On June 13, 2023, upon terminating Mr. Faulstick, the Company appointed Michael Seckler, 58, to the position of Interim Chief Executive Officer, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001062993-23-013870

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.